On April 28, 2024, CareMetx, a leading technology enabled hub services platform facilitating patient access to specialty medications, acquired PX Technology, a pioneer in digitizing healthcare processes.
Kroll’s Transaction Advisory Services team provided financial due diligence services to CareMetx in connection with the transaction.
About CareMetx
CareMetx, LLC is a leading technology-enabled hub services platform facilitating patient access to specialty medications. Serving pharmaceutical, biotechnology and device manufacturers, CareMetx leverages digital eServices integrated in a cohesive platform to promote efficiency in the healthcare ecosystem and remove barriers for patients and providers. CareMetx is committed to delivering compassionate advocacy to patients, decision-making data, and confidence-building insight to manufacturer clients. Headquartered in Bethesda, Maryland, CareMetx serves more than 80 brands.
About PX Technology
PX Technology is a pioneer in digitizing healthcare processes to enhance patient access to therapies. With its flagship platform, PX Connect, the company simplifies the patient enrollment process for healthcare providers, offering a seamless solution that integrates into existing workflows. PX Technology's mission is to streamline the bridge between patients and their access to necessary treatments, focusing on efficiency, innovation, and the improvement of patient care through technology. For more information, visit their website at PX Technology.
